慢性阻塞性肺疾病患者经导管与外科主动脉瓣置换术的比较数据集

数据集获取（Figshare）

• 源站标题：Transcatheter versus surgical aortic valve replacement in patients with chronic obstructive pulmonary disease
• DOI：10.6084/m9.figshare.13489719.v1
• 发布日期：2020-12-26
• 文件数：2 个
• 文件总体积：32.34 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Transcatheter_versus_surgical_aortic_valve_replacement_in_patients_with_chronic_obstructive_pulmonary_disease/13489719

命令行下载

curl -L -o "SCAR-2020-OR-0137.R1 Suppl Tab S1.docx" "https://ndownloader.figshare.com/files/25893312"
curl -L -o "SCAR-2020-OR-0137.R1 Suppl Tab S2.docx" "https://ndownloader.figshare.com/files/25893315"

文件清单

• SCAR-2020-OR-0137.R1 Suppl Tab S1.docx（18.42 KB）
• SCAR-2020-OR-0137.R1 Suppl Tab S2.docx（13.92 KB）

文件总体积 32.34 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Although a number of studies compared mortality after transcatheter aortic valve implantation (TAVI) with that after surgical aortic replacement (SAVR) in patients with chronic obstructive pulmonary disease (COPD), no meta-analysis of them has been conducted to date. To determine whether TAVI or SAVR is associated with better postprocedural survival in patients with COPD, a meta-analysis of all studies currently available was performed. Design. To identify all comparative studies of TAVI with SAVR in patients with COPD, PubMed and Web of Science were searched through January 2020. Studies meeting the following criteria were included in the present meta-analysis: the design was an observational comparative study or a randomized controlled trial; the study population was patients with COPD; patients were assigned to TAVI versus SAVR; and outcomes included all-cause mortality. Adjusted (if unavailable, unadjusted) odds or hazard ratios with their confidence intervals (CIs) of mortality for TAVI versus SAVR were extracted from each study. Study-specific estimates were combined in the random-effects model. Results. Six eligible studies with a total of 4771 patients with COPD were identified and included in the present meta-analysis. The meta-analysis indicated significantly lower early (in-hospital or 30-day) mortality after TAVI than after SAVR (odds ratio, 0.69; 95% CI, 0.53–0.90; p = .006) but no significant difference in midterm (1-year to 5-year) mortality between TAVI and SAVR (hazard ratio, 1.07; 95% CI, 0.79–1.44; p = .68). Conclusions. In patients with COPD, TAVI was associated with reduced early mortality, while midterm mortality appeared similar, as compared with SAVR.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.13489719.v1（source: https://tandf.figshare.com/articles/dataset/Transcatheter_versus_surgical_aortic_valve_replacement_in_patients_with_chronic_obstructive_pulmonary_disease/13489719）。